Safety Reference
Warning
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
Sourcing Letermovir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Inosine pranobex
pharmaceutical raw material
Sourcing Letermovir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Letermovir is an antiviral active pharmaceutical ingredient used to prevent cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those undergoing allogeneic stem cell transplants. It is a research compound developed for pharmaceutical manufacturing and supply.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Letermovir (CAS 917389-32-3) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
FWYSMLBETOMXAG-QHCPKHFHSA-N
COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O